Hybrid composites of phosphomolybdic acid@UiO-66(PMo12@UiO-66)and Co-substituted phosphomolybdic acid@UiO-66(PMo11Co@UiO-66)were synthesized using the direct solvothermal method.A variety of characterization results d...Hybrid composites of phosphomolybdic acid@UiO-66(PMo12@UiO-66)and Co-substituted phosphomolybdic acid@UiO-66(PMo11Co@UiO-66)were synthesized using the direct solvothermal method.A variety of characterization results demonstrated that phosphomolybdic acid(PMo12)or Co-substituted phosphomolybdate acid(PMo11Co)clusters are uniformly dispersed in the cages of Zr-based metal-organic UiO-66 frameworks.The catalytic properties of these hybrid composites were investigated by applying the epoxidation of olefins with tert-butyl hydroperoxide as the oxidant.Compared to PMo12@UiO-66,PMo11Co@UiO-66 showed a much higher catalytic activity and was simply recovered by filtration and reused for at least ten runs without significant loss of catalytic activity.Particularly,PMo11Co@UiO-66 can efficiently convert cyclic olefins like limonenes to epoxides,and its selectivity to 1,2-limonene oxide reached 91%in the presence of a radical inhibitor such as hydroquinone.The excellent catalytic activity and stability of the hybrid composite PMo11Co@UiO-66 are mainly attributed to the uniform distribution of highly active PMo11Co units within the smaller cages of UiO-66,to the suitable surface polarity of the hybrid composite for facilitating the access of reagents and solvent,and to the strong interface-interactions between the polyoxometalate and the UiO-66 framework.展开更多
Prolonged antiretroviral therapy(ART)-free remission post-treatment has been observed and reported in human immunodeficiency virus-1(HIV-1)infection.The primary factors for such achievement have been linked to the tra...Prolonged antiretroviral therapy(ART)-free remission post-treatment has been observed and reported in human immunodeficiency virus-1(HIV-1)infection.The primary factors for such achievement have been linked to the transcriptional inactivation of HIV-1 DNA and immune recovery.Here,we reported a patient with acute HIV-1 infection who immediately received intensified quadruple ART.At month 9(M9),an old CFDA-approved immuno-suppressive herbal medicine,Tripterygium Wilfordii Hook F(TwHF),was used in addition to ART.The patient was closely monitored.Virological and immunological tests as well as transcriptome analysis were carried out at each visit.The results showed that TwHF reduced serum IP-10 level and inhibited T cell activation.Both ART and TwHF were discontinued in M24,and levels of peripheral blood HIV-1 RNA and DNA remained suppressed for consecutive 12months.With transcriptome analysis,we found pattern changes linking immuno-activation and amino acid metabolism with viral suppression and rebound.This indicates that the intentional suppression of immuno-activation is a promising approach for a functional cure of HIV-1 infection.展开更多
文摘Hybrid composites of phosphomolybdic acid@UiO-66(PMo12@UiO-66)and Co-substituted phosphomolybdic acid@UiO-66(PMo11Co@UiO-66)were synthesized using the direct solvothermal method.A variety of characterization results demonstrated that phosphomolybdic acid(PMo12)or Co-substituted phosphomolybdate acid(PMo11Co)clusters are uniformly dispersed in the cages of Zr-based metal-organic UiO-66 frameworks.The catalytic properties of these hybrid composites were investigated by applying the epoxidation of olefins with tert-butyl hydroperoxide as the oxidant.Compared to PMo12@UiO-66,PMo11Co@UiO-66 showed a much higher catalytic activity and was simply recovered by filtration and reused for at least ten runs without significant loss of catalytic activity.Particularly,PMo11Co@UiO-66 can efficiently convert cyclic olefins like limonenes to epoxides,and its selectivity to 1,2-limonene oxide reached 91%in the presence of a radical inhibitor such as hydroquinone.The excellent catalytic activity and stability of the hybrid composite PMo11Co@UiO-66 are mainly attributed to the uniform distribution of highly active PMo11Co units within the smaller cages of UiO-66,to the suitable surface polarity of the hybrid composite for facilitating the access of reagents and solvent,and to the strong interface-interactions between the polyoxometalate and the UiO-66 framework.
基金This study was supported by the National Natural Science Foundation of China(No.81601777)National Key Technologies R&D Program for the 13th Five-year Plan(No.2017ZX10202101,2018ZX10732101-002)the CAMS Initiative for Innovative Medicine(CAMS-I2M:2017-I2M-1-014).
文摘Prolonged antiretroviral therapy(ART)-free remission post-treatment has been observed and reported in human immunodeficiency virus-1(HIV-1)infection.The primary factors for such achievement have been linked to the transcriptional inactivation of HIV-1 DNA and immune recovery.Here,we reported a patient with acute HIV-1 infection who immediately received intensified quadruple ART.At month 9(M9),an old CFDA-approved immuno-suppressive herbal medicine,Tripterygium Wilfordii Hook F(TwHF),was used in addition to ART.The patient was closely monitored.Virological and immunological tests as well as transcriptome analysis were carried out at each visit.The results showed that TwHF reduced serum IP-10 level and inhibited T cell activation.Both ART and TwHF were discontinued in M24,and levels of peripheral blood HIV-1 RNA and DNA remained suppressed for consecutive 12months.With transcriptome analysis,we found pattern changes linking immuno-activation and amino acid metabolism with viral suppression and rebound.This indicates that the intentional suppression of immuno-activation is a promising approach for a functional cure of HIV-1 infection.
